International experts have endorsed antipsychotics as first-line treatment and closer dermatology–psychiatry collaboration for delusional infestation, while remaining divided on whether patients should be explicitly told the diagnosis, according to a new Delphi consensus study.
The majority agreed that antipsychotic medication should be offered as first-line therapy and backed prescribing by appropriately trained dermatologists, recognising that many patients first present to dermatology clinics and may be reluctant to engage with psychiatric services.
The study has been published this month in the Journal of the European Academy of Dermatology & Venerology .
Delusional infestation (DI) is a psychiatric disorder defined as a fixed false belief of being infested with animate or inanimate material in the absence of objective medical evidence.
“Patients often report tactile hallucinations or abnormal skin sensations, leading to significant distress and frequent healthcare encounters involving various professionals,” the researchers wrote.

